Patents by Inventor Michael V. Sefton

Michael V. Sefton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120171258
    Abstract: Scaleable, vascularised tissue constructs that are composed of a multiplicity of cell containing, discrete and separable modules, methods of fabricating same and uses thereof. The tissue construct is a tissue substitute used in tissue transplantation or substitution or for the purpose of in vitro mimic of normal tissue.
    Type: Application
    Filed: February 29, 2012
    Publication date: July 5, 2012
    Inventors: Michael V. Sefton, Alison McGuigan
  • Publication number: 20100316690
    Abstract: Scaleable, vascularised tissue constructs that are composed of a multiplicity of cell containing, discrete and separable modules, methods of fabricating same and uses thereof. The tissue construct is a tissue substitute used in tissue transplantation or substitution or for the purpose of in vitro mimic of normal tissue.
    Type: Application
    Filed: June 12, 2009
    Publication date: December 16, 2010
    Inventors: Michael V. Sefton, Alison McGuigan
  • Publication number: 20040213758
    Abstract: Therapeutic polymers containing hydroxamate group that binds and thus inhibits zinc containing enzymes such as matrix metalloproteinases. The implantation of such material inhibits remodeling in its vicinity.
    Type: Application
    Filed: April 23, 2003
    Publication date: October 28, 2004
    Applicant: Rimon Therapeutics Ltd.
    Inventors: Michael V. Sefton, Michael H. May, Gary A. Skarja
  • Publication number: 20030228290
    Abstract: A vascularised tissue construct seeded with endothelial cells is disclosed. A modular, scalable method of fabrication of tissue constructs with a uniform cell distribution that can accommodate multiple cell types, and in which the porosity is created after cell incorporation, is disclosed. The construct is based on the porous structure that is created when a column or tube is randomly packed with solid objects, such as cylindrical rods. Cells, such as liver cells, are encapsulated in solid gelatin rods (200 &mgr;m diameter, aspect ratio 1:5) on to which if desired endothelial cells, such as human umbilical vein endothelial cells (HUVEC), can adhere. The gelatin rods are randomly packed into a larger tube and then coated with HUVEC in one embodiment. The interstitial gaps among the rods form interconnected channels that are lined by the endothelial cells. The resulting endothelial cell lining enables whole blood to percolate around the rods and through the interstitial channels.
    Type: Application
    Filed: June 4, 2003
    Publication date: December 11, 2003
    Inventors: Michael V. Sefton, Alison McGuigan
  • Patent number: 4353888
    Abstract: Viable mammalian cells are encapsulated in a polymeric membrane to form microencapsulated beads ready for introduction into a host body. The polymeric membrane allows passage therethrough of cell substrates and secretions, but prevents passage of larger molecules such as proteinaceous antibodies. In this way viable cells secreting essential products such as pancreatic islet cells secreting insulin can be transplanted into a host, and be protected against the immune reactions of the antibodies of the host which would otherwise reject the foreign cells. The cells are encapsulated from suspension in a non-solvent such as PPG, by addition thereto of a solution of a polymer (e.g. an acrylic/methacrylic acid esters copolymer) in dimethylsulfoxide. The polymer precipitates onto the cells to encapsulate them, and the supernatants are removed.
    Type: Grant
    Filed: December 23, 1980
    Date of Patent: October 12, 1982
    Inventor: Michael V. Sefton
  • Patent number: 4209014
    Abstract: An implantable device for dispensing a medicament in two modes; a basal delivery rate and an augmented rate. The device includes a permeable elastic material adapted to be repeatedly compressed by a solenoid operated piston. The device delivers a basal rate when the piston is inoperative and an augmented rate when the permeable elastic material is compressed. The device is suitable for delivering insulin in an "artificial endocrine pancreas".
    Type: Grant
    Filed: December 12, 1977
    Date of Patent: June 24, 1980
    Assignee: Canadian Patents and Development Limited
    Inventor: Michael V. Sefton